- Trials with a EudraCT protocol (13)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
13 result(s) found for: Coagulase.
Displaying page 1 of 1.
EudraCT Number: 2017-003612-39 | Sponsor Protocol Number: INF-BACT-2017 | Start Date*: 2018-04-25 | |||||||||||
Sponsor Name:Fundació Parc Taulí | |||||||||||||
Full Title: Randomized clinical trial on the need for antibiotic to treat low-risk catheter bacteremia due to coagulase-negative staphylococci. | |||||||||||||
Medical condition: Catheter bacteremia caused by coagulase-negative staphylococci. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-000232-12 | Sponsor Protocol Number: SYNC-01-AC-P1 | Start Date*: 2007-01-31 |
Sponsor Name:Syntopix Group plc | ||
Full Title: Novel topical therapies for acne vulgaris: a randomised, controlled, double blind comparison of the antibacterial efficacy of 1% w/v formulations of tert-butylhydroquinone, zinc pyrithione and benz... | ||
Medical condition: Healthy volunteer study. The product under development will be used for the treatment of acne vulgaris. | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults | Gender: Male | |
Trial protocol: GB (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2008-003284-39 | Sponsor Protocol Number: LEVOF_L_03815 | Start Date*: 2008-07-22 | |||||||||||
Sponsor Name:sanofi-aventis France | |||||||||||||
Full Title: Etude nationale, multicentrique, non comparative, évaluant l’efficacité de l’association lévofloxacine (500 mg) et rifampicine (600 ou 900 mg selon le poids) administrée une fois par jour par voie ... | |||||||||||||
Medical condition: infections sur prothèses ostéo-articulaires (IPOA) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-007062-38 | Sponsor Protocol Number: EC07/90316 | Start Date*: 2008-04-22 |
Sponsor Name:Fundación Investigación Biomédica Hospital General Universitario Gregorio Marañón (FIBHGUGM) | ||
Full Title: “Necesidad de tratamiento antibiótico de la bacteriemia relacionada con catéteres venosos centrales producida por Staphylococcus coagulasa-negativa tras la retirada del catéter en pacientes de bajo... | ||
Medical condition: Estudiar la necesidad de tratamiento antibiótico en pacientes con BRC por SCN, con bajo riesgo de desarrollo de complicaciones, tras la retirada de dichos catéteres. To study need for antimicrobia... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2013-000469-35 | Sponsor Protocol Number: 4 | Start Date*: 2013-09-18 |
Sponsor Name:Hillerød Hospital | ||
Full Title: Peroral antibiotic treatment of endocarditis | ||
Medical condition: Bacterial endocarditis caused by streptococci, enterococci, staphylococcus aureus or coagulase-negative staphylococci | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NO (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2006-005453-30 | Sponsor Protocol Number: DAP-OST-06-02 | Start Date*: 2007-09-11 | |||||||||||
Sponsor Name:Cubist Pharmaceuticals, Inc. | |||||||||||||
Full Title: A Phase 2 Randomized Study Investigating the Safety, Efficacy and Pharmacokinetics of Daptomycin 6 mg/kg and 8 mg/kg Versus Comparator in the Treatment of Subjects Undergoing Surgical Standard of ... | |||||||||||||
Medical condition: Treatment of subjects undergoing surgical standard of care for osteomyelitis associated with an infected prosthetic hip or knee joint caused by methicillin-resistant Staphylococcus Aureus and/or co... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-019984-12 | Sponsor Protocol Number: AMNCH-TCD-CHG-1-2010 | Start Date*: 2010-07-21 |
Sponsor Name:Adelaide & Meath Hospital, incorporating The National Children's Hospital | ||
Full Title: A multicentre randomised trial comparing the effects of 2% chlorhexidine gluconate in 70% isopropyl alcohol as a skin, exit site and catheter hub cleansing agent versus other forms of chlorhexidine... | ||
Medical condition: Prevention of central venous catheter-related infections in haemodialysis patients. This trial will evaluate the effectiveness of 2% chlorhexidine gluconate in 70%isopropyl alcohol as a skin, exit... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: IE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2012-003447-29 | Sponsor Protocol Number: DAP-PEDBAC-11-02 | Start Date*: 2013-06-11 | |||||||||||
Sponsor Name:Cubist Pharmaceuticals, Inc. | |||||||||||||
Full Title: A COMPARATIVE EVALUATION OF THE SAFETY AND EFFICACY OF DAPTOMYCIN VERSUS STANDARD OF CARE IN PEDIATRIC SUBJECTS TWO - SEVENTEEN YEARS OF AGE WITH BACTEREMIA CAUSED BY STAPHYLOCOCCUS AUREUS. | |||||||||||||
Medical condition: Bacteremia caused by Staphylococcus Aureus. | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) ES (Completed) HU (Completed) GR (Completed) Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-000471-20 | Sponsor Protocol Number: RIPH_2019_01 | Start Date*: 2020-11-30 | |||||||||||
Sponsor Name:CH Tourcoing | |||||||||||||
Full Title: Rifabutin versus rifampicin for treatment of staphylococcal prosthetic joint infection treated with debridement, antibiotics and implant retention (DAIR strategy): a multicenter randomized, open-la... | |||||||||||||
Medical condition: Adult with an staphylococcal prosthetic joint infection treated with debridement, antibiotics and implant retention (DAIR strategy) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-005159-32 | Sponsor Protocol Number: A5951105 | Start Date*: 2005-04-28 | |||||||||||
Sponsor Name:Pfizer Limited | |||||||||||||
Full Title: Linezolid vs Vancomycin/Cefazolin in the treatment of hemodialysis patients with catheter-related gram-positive bloodstream infections | |||||||||||||
Medical condition: Catheter-related Gram-positive bloodstream infections. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SK (Completed) DE (Prematurely Ended) IT (Prematurely Ended) ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-001699-43 | Sponsor Protocol Number: BPR-CS-009 | Start Date*: 2018-12-13 | |||||||||||
Sponsor Name:Basilea Pharmaceutica International Ltd | |||||||||||||
Full Title: A randomized, double-blind, multi-center study to establish the efficacy and safety of ceftobiprole medocaril compared to daptomycin in the treatment of Staphylococcus aureus bacteremia, including ... | |||||||||||||
Medical condition: Complicated staphylococcus aureus bacteremia (cSAB) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) HU (Completed) BG (Completed) ES (Completed) IT (Completed) GR (Completed) PT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-021242-22 | Sponsor Protocol Number: PHRN09-LB / DATIPO | Start Date*: 2011-07-26 | |||||||||||
Sponsor Name:CHRU de Tours | |||||||||||||
Full Title: Etude multicentrique, de non infériorité, randomisée, ouverte, évaluant l’efficacité de deux Durées d’Antibiothérapie (6 semaines versus 12 semaines) dans le Traitement des Infections sur Prothèses... | |||||||||||||
Medical condition: Infection sur prothèse ostéo-articulaire | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-001024-34 | Sponsor Protocol Number: OraPAT-IE-GAMES | Start Date*: 2021-12-15 | |||||||||||
Sponsor Name:Fundació Clínic per a la Recerca Biomèdica | |||||||||||||
Full Title: Oral antimicrobial treatment vs. outpatient parenteral for infective endocarditis. | |||||||||||||
Medical condition: infective endocarditis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
